A rabbit anti-human CD38 antibody for eliminating daratumumab and isatuximab interference in immunohematology testing. [PDF]
Zhang L +9 more
europepmc +1 more source
Abstract Background Functional high‐risk (FHR) multiple myeloma (MM) was historically defined as progression within 18 months of starting therapy, with expected subsequent overall survival (OS) <2 years. The optimal definition of FHR in the era of combined quadruplet therapy (QUAD) + autologous stem cell transplantation (ASCT) is unknown.
Gayathri Ravi +9 more
wiley +1 more source
CD38 expression by neonatal human naive CD4+ T cells shapes their distinct metabolic and tolerogenic properties. [PDF]
Dwyer LR +14 more
europepmc +1 more source
Immunological characteristics of children with autism spectrum disorder and comorbid atopic dermatitis. [PDF]
Shi H +12 more
europepmc +1 more source
What's new? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado +54 more
wiley +1 more source
Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma. [PDF]
Iriuchishima H +6 more
europepmc +1 more source
The Level and Clinical Significance of B Lymphocytes and Immune Molecules (IL-4, IL-10, BAFF, and IgD) in Psoriasis. [PDF]
Wu B +7 more
europepmc +1 more source
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy. [PDF]
Cheddadi Y +6 more
europepmc +1 more source
Expression of CD38<sup>+</sup>CD8<sup>+</sup> T cells in hepatitis B-related acute-on-chronic liver failure and its prognostic value. [PDF]
Li J +6 more
europepmc +1 more source

